With the occurrence of hypertensive diseases, the number of patients suffering from hypertensive heart disease is also increasing, which can cause great harm to the heart of patients, and the disease should be detected early and treated early. There are many kinds of treatment methods for the disease, and the following is a detailed introduction for you. 1. Early control of blood pressure Early reduction of blood pressure to achieve the standard is the first task in the treatment of hypertensive heart disease, should be considered SBP target value <140mmHg. 2. The importance of reversing LVH The Framinghan Heart Study has confirmed through long-term follow-up that LVH is reduced and cardiovascular mortality decreases. Reversal of LVH includes non-pharmacological treatments: lifestyle optimization, low salt diet; weight control; alcohol restriction; reduction of certain sympathetic active hormones, such as elevated catecholamines, renin angiotensin system (RAS) activation stress state, etc. Among the antihypertensive drugs, angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-converting enzyme receptor antagonists (ARB) may prevent the occurrence of LVH and myocardial fibrosis. Animal experiments and human studies have also confirmed that calcium antagonists (CCB) can reverse LVH. 3. Treatment of heart failure The mortality rate of heart failure is high once the symptoms become apparent, so it is important to strengthen the prevention and treatment of early asymptomatic heart failure (systolic or diastolic hypokinesia). For systolic heart failure, ACEI, β-blockers, diuretics, ARB and/or aldosterone inhibitors are recommended to reduce mortality and hospitalization rates. In hypertensive patients with diastolic heart failure (heart failure with preserved ejection fraction), there is no evidence to date that antihypertensive therapy or any antihypertensive drug is beneficial. However, in these patients and in patients with hypertension combined with decreased systolic function, lowering SBP to below 140 mmHg should be considered. 4. Treatment of combined coronary artery disease There are multiple risk factors that can contribute to coronary artery disease, but blood pressure levels are one of the important ones. Blood pressure levels are associated with the risk of coronary heart disease over a wide range, and the risk of coronary heart disease increases sharply after SBP >140 mmHg. For hypertensive patients with comorbid coronary artery disease, the target value for blood pressure lowering is <140 mm Hg. For patients with a recent history of heart attack, beta-blockers are recommended. For other patients with coronary artery disease, all blood pressure-lowering drugs are available, and beta-blockers and calcium antagonists are recommended in preference for the sake of relieving angina symptoms. 5. Treatment of combined atrial fibrillation Hypertension is the most common comorbidity of atrial fibrillation and may also be a reversible causative factor of atrial fibrillation. Patients with hypertension combined with atrial fibrillation should be adequately evaluated for risk of thromboembolism, and most patients should receive oral anticoagulation to prevent stroke and other embolic events, unless contraindicated. AECI or ARB is recommended to prevent atrial fibrillation in patients with hypertension combined with left ventricular hypertrophy or cardiac insufficiency; there is also evidence that beta-blockers with aldosterone antagonists may also prevent the development of atrial fibrillation. Hypertensive heart disease will be controlled after treatment, but it is very difficult to be cured. Patients should prevent blood pressure from rising in their lives, because hypertensive heart disease will worsen with the rise of blood pressure, so patients should prevent hypertensive heart disease and take good care of their body, which can effectively control the disease.